New Wave Holdings Corp.

  • Market Cap: Micro Cap
  • Industry: Finance
  • ISIN: CA64913V5099
CAD
0.50
-0.09 (-15.25%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Finance

stock-summary
Market cap

CAD 25 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

-125.67%

stock-summary
Price to Book

5.85

Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Dec 2025)
Net Profit:
-1 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-18.03%
0%
-18.03%
6 Months
-20.63%
0%
-20.63%
1 Year
566.67%
0%
566.67%
2 Years
400.0%
0%
400.0%
3 Years
2400.0%
0%
2400.0%
4 Years
-88.51%
0%
-88.51%
5 Years
400.0%
0%
400.0%

New Wave Holdings Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-2.52%
EBIT Growth (5y)
1.33%
EBIT to Interest (avg)
-2.25
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
5.85
EV to EBIT
-3.72
EV to EBITDA
-3.72
EV to Capital Employed
-19.74
EV to Sales
19.74
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-125.67%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Sep 2025",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 64.00% vs -2,400.00% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "-0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.90",
          "val2": "-2.50",
          "chgp": "64.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.90",
          "val2": "-2.50",
          "chgp": "64.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "-154,365.20%",
          "chgp": "15,436.52%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 100.00% vs 0.00% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 14.29% vs -90.91% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "-0.20",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.10",
          "val2": "-2.00",
          "chgp": "-5.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.30",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.80",
          "val2": "-2.10",
          "chgp": "14.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-185,750.60%",
          "val2": "0.00%",
          "chgp": "-18,575.06%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
-0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.90
-2.50
64.00%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-0.90
-2.50
64.00%
Operating Profit Margin (Excl OI)
0.00%
-154,365.20%
15,436.52%
USD in Million.
Net Sales

QoQ Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 64.00% vs -2,400.00% in Sep 2025

Annual Results Snapshot (Consolidated) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
0.00
-0.20
100.00%
Operating Profit (PBDIT) excl Other Income
-2.10
-2.00
-5.00%
Interest
0.00
0.00
Exceptional Items
0.30
0.00
Consolidate Net Profit
-1.80
-2.10
14.29%
Operating Profit Margin (Excl OI)
-185,750.60%
0.00%
-18,575.06%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 100.00% vs 0.00% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 14.29% vs -90.91% in Mar 2024

stock-summaryCompany CV
About New Wave Holdings Corp. stock-summary
stock-summary
New Wave Holdings Corp.
Finance
New Wave Holdings Corp, formerly New Wave Esports Corp, is a Canada-based healthcare, esports and competitive gaming company. The Company provides capital and support services to esports organizations, teams, leagues, events, platforms, tools, and technology innovators. Its portfolio includes Avatar One Esports Capital Corp, Even Matchup Gaming, PlayLine, Talon Esports, Thunderbolt CDG and Tiidal Gaming. Avatar One Esports Capital Corp is an esports acquisition vehicle. Even Matchup Gaming is an events company. PlayLine is a daily Daily fantasy sports betting platform company. Talon Esports is a professional esports team operator. The Company’s psychedelic sector is focused on active psychedelic compounds, functional mushroom product lines, and to develop a portfolio focusing on psilocybin, lysergic acid diethylamide (LSD), methylenedioxymethamphetamine (MDMA), and ketamine derived treatments for neuropsychiatric diseases.
Company Coordinates stock-summary
Company Details
401 - 217 Queen Street, Suie , THE JUNCTION ON : M5V 0R2
stock-summary
Tel: 1 604 65770041 604 5597333
stock-summary
stock-summary
Registrar Details